- Home
- NCLH vs RVMD Comparison
NCLH vs RVMD Comparison
Compare NCLH & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCLH
- RVMD
- Stock Information
- Founded
- NCLH 1966
- RVMD 2014
- Country
- NCLH United States
- RVMD United States
- Employees
- NCLH N/A
- RVMD N/A
- Industry
- NCLH Marine Transportation
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NCLH Consumer Discretionary
- RVMD Health Care
- Exchange
- NCLH Nasdaq
- RVMD Nasdaq
- Market Cap
- NCLH 9.3B
- RVMD 8.7B
- IPO Year
- NCLH 2013
- RVMD 2020
- Fundamental
- Price
- NCLH $19.14
- RVMD $37.29
- Analyst Decision
- NCLH Buy
- RVMD Strong Buy
- Analyst Count
- NCLH 17
- RVMD 13
- Target Price
- NCLH $29.00
- RVMD $67.77
- AVG Volume (30 Days)
- NCLH 15.8M
- RVMD 1.2M
- Earning Date
- NCLH 04-30-2025
- RVMD 05-07-2025
- Dividend Yield
- NCLH N/A
- RVMD N/A
- EPS Growth
- NCLH 384.69
- RVMD N/A
- EPS
- NCLH 1.89
- RVMD N/A
- Revenue
- NCLH $9,479,651,000.00
- RVMD N/A
- Revenue This Year
- NCLH $9.77
- RVMD N/A
- Revenue Next Year
- NCLH $10.43
- RVMD $153.09
- P/E Ratio
- NCLH $10.13
- RVMD N/A
- Revenue Growth
- NCLH 10.87
- RVMD N/A
- 52 Week Low
- NCLH $14.69
- RVMD $29.55
- 52 Week High
- NCLH $29.29
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- NCLH 34.92
- RVMD 42.92
- Support Level
- NCLH $19.25
- RVMD $37.42
- Resistance Level
- NCLH $20.88
- RVMD $39.59
- Average True Range (ATR)
- NCLH 0.83
- RVMD 1.32
- MACD
- NCLH 0.23
- RVMD 0.05
- Stochastic Oscillator
- NCLH 45.28
- RVMD 29.10
About NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 66,500). It operates 32 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 41,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.